Core Viewpoint - The company is transitioning from a "small oral care" focus to a "large oral health" strategy, expanding its product and service offerings in the oral health sector, including smart oral care, oral beauty, and oral medical services [2][4]. Company Strategy and Product Development - The company is implementing a multi-brand and multi-category development strategy, with core brands including "Dengkang" and "Cold Acid Spirit," and plans to expand into four major business segments: oral care, oral medical, oral beauty, and oral capital management [3][4]. - In 2024, the company's revenue from oral medical and beauty care products increased by 35.45%, laying a solid foundation for entering the oral health industry [2]. Financial Performance - In 2024, the company achieved a revenue of 1.56 billion yuan, a year-on-year increase of 13.40%, and a net profit of 161 million yuan, up 14.07% [10]. - The company's gross profit margin for 2024 was 32%, an increase of 25 percentage points year-on-year, driven by product structure optimization, rapid online channel expansion, and improved production efficiency through smart factories [6]. Market Trends and Consumer Behavior - The oral care industry is experiencing a shift towards high-end and professional products, driven by increased consumer awareness of oral health and changing demographics [5]. - The rise of e-commerce and content-driven retail is reshaping consumer shopping habits, with traditional retail channels undergoing significant transformation [5]. Shareholder Returns and Corporate Governance - The company plans to distribute a cash dividend of 5 yuan per 10 shares for 2024, with a cash dividend rate of approximately 80%, reflecting its commitment to shareholder returns [9][10]. - The company emphasizes the protection of minority shareholders' rights and aims to enhance information disclosure and investor relations management [14]. Innovation and Technology - The company has developed unique dual sensitivity technology and bio-glass ceramic materials, which have been clinically validated to effectively address tooth sensitivity issues [15].

Group 1: Company Strategy and Market Position - The company aims to transition from "small oral care" to "large oral health" by expanding into smart oral care, oral beauty, and oral medical services, with a revenue growth of 35.45% in oral medical and beauty care products in 2024 [2][3] - The company employs a multi-brand strategy with core brands including "Dengkang" and "Cold Acid Spirit," targeting various consumer segments with a diverse product matrix [3] - The focus is on becoming a world-leading oral health expert, enhancing market share and competitiveness through a dedicated strategy in the oral health sector [3] Group 2: Industry Trends and Consumer Behavior - Rising awareness of oral health among consumers is driving demand for high-end and professional oral care products, with a shift towards rational and experiential consumption [4] - E-commerce channels are growing rapidly, while traditional retail is undergoing significant transformation, leading to increased competition in the market [4] Group 3: Financial Performance and Projections - The company reported a gross profit margin of 49.32% in 2024, an increase of 5.25 percentage points, driven by an optimized product mix and expansion in online sales [5] - The net profit growth of 27.07% in 2024 is attributed to increased sales scale and product upgrades [5] - Operating cash flow increased by 20.09% year-on-year, reflecting sustained growth in sales and net profit [5][8] Group 4: Shareholder Returns and Corporate Governance - The 2024 dividend plan proposes a payout of 7.5 CNY per 10 shares, with a cash dividend rate of approximately 80%, aligning with regulatory encouragement for higher investor returns [6] - The company emphasizes the protection of minority shareholders' rights and has consistently improved its dividend policy since listing [11] Group 5: Inventory and Supply Chain Management - Inventory increased by 15.64% in line with sales growth, indicating a healthy inventory turnover rate [8]

重庆登康口腔护理用品股份有限公司 （地址：重庆市江北区海尔路 389 号） 首次公开发行股票并在主板上市 招股说明书 一、重要声明 中国证监会、交易所对本次发行所作的任何决定或意见，均不表明其对发 行人注册申请文件及所披露信息的真实性、准确性、完整性作出保证，也不表 明其对发行人的盈利能力、投资价值或者对投资者的收益作出实质性判断或保 证。任何与之相反的声明均属虚假不实陈述。 根据《证券法》规定，股票依法发行后，发行人经营与收益的变化，由发 行人自行负责；投资者自主判断发行人的投资价值，自主作出投资决策，自行 承担股票依法发行后因发行人经营与收益变化或者股票价格变动引致的投资风 险。 | 二、发行概况 | | --- | 保荐人（主承销商） 1-1-1 （住所：北京市朝阳区安立路 66 号 4 号楼） 重庆登康口腔护理用品股份有限公司 招股说明书 声明与发行概况 招股说明书 | 二、发行人所处行业基本状况及公司竞争地位…………………………………………………………123 | | --- | | 三、发行人的销售情况及主要客户 | | 四、发行人的采购情况和主要供应商. | | 五、发行人的主要固定资产及无形资产 ...

首次公开发行股票并在主板上市 招股意向书 保荐人（主承销商） 重庆登康口腔护理用品股份有限公司 （地址：重庆市江北区海尔路 389 号） 1-1-1 （住所：北京市朝阳区安立路 66 号 4 号楼） 重庆登康口腔护理用品股份有限公司 招股意向书 声明与发行概况 一、重要声明 中国证监会、交易所对本次发行所作的任何决定或意见，均不表明其对发 行人注册申请文件及所披露信息的真实性、准确性、完整性作出保证，也不表 明其对发行人的盈利能力、投资价值或者对投资者的收益作出实质性判断或保 证。任何与之相反的声明均属虚假不实陈述。 根据《证券法》规定，股票依法发行后，发行人经营与收益的变化，由发 行人自行负责；投资者自主判断发行人的投资价值，自主作出投资决策，自行 承担股票依法发行后因发行人经营与收益变化或者股票价格变动引致的投资风 险。 | 二、发行概况 | | --- | 招股意向书 | 二、发行人所处行业基本状况及公司竞争地位………………………………………………………………………………………122 | | --- | | 三、发行人的销售情况及主要客户 | | 四、发行人的采购情况和主要供应商. | | 五、发行人的 ...

重庆登康口腔护理用品股份有限公司 （地址：重庆市江北区海尔路 389 号） 首次公开发行股票并在主板上市 招股说明书 （注册稿） 声明：本公司的发行申请尚需经深圳证券交易所和中国证监会履行相应 程序。本招股说明书不具有据以发行股票的法律效力，仅供预先披露之用。 投资者应当以正式公告的招股说明书作为投资决定的依据。 保荐人（主承销商） （住所：北京市朝阳区安立路 66 号 4 号楼） 1-1-1 重庆登康口腔护理用品股份有限公司 招股说明书 声明与发行概况 一、重要声明 中国证监会、交易所对本次发行所作的任何决定或意见，均不表明其对发 行人注册申请文件及所披露信息的真实性、准确性、完整性作出保证，也不表 明其对发行人的盈利能力、投资价值或者对投资者的收益作出实质性判断或保 证。任何与之相反的声明均属虚假不实陈述。 根据《证券法》规定，股票依法发行后，发行人经营与收益的变化，由发 行人自行负责；投资者自主判断发行人的投资价值，自主作出投资决策，自行 承担股票依法发行后因发行人经营与收益变化或者股票价格变动引致的投资风 险。 | 发行股票类型 | 人民币普通股（A 股） | | --- | --- | | 发行股数 ...

重庆登康口腔护理用品股份有限公司 （地址：重庆市江北区海尔路 389 号） 首次公开发行股票并在主板上市 招股说明书 （上会稿） 声明：本公司的发行申请尚需经深圳证券交易所和中国证监会履行相应 程序。本招股说明书不具有据以发行股票的法律效力，仅供预先披露之用。 投资者应当以正式公告的招股说明书作为投资决定的依据。 保荐人（主承销商） （住所：北京市朝阳区安立路 66 号 4 号楼） 1-1-1 重庆登康口腔护理用品股份有限公司 招股说明书 声明与发行概况 一、重要声明 中国证监会、交易所对本次发行所作的任何决定或意见，均不表明其对发 行人注册申请文件及所披露信息的真实性、准确性、完整性作出保证，也不表 明其对发行人的盈利能力、投资价值或者对投资者的收益作出实质性判断或保 证。任何与之相反的声明均属虚假不实陈述。 根据《证券法》规定，股票依法发行后，发行人经营与收益的变化，由发 行人自行负责；投资者自主判断发行人的投资价值，自主作出投资决策，自行 承担股票依法发行后因发行人经营与收益变化或者股票价格变动引致的投资风 险。 | 发行股票类型 | 人民币普通股（A 股） | | --- | --- | | 发行股数 ...

重庆登康口腔护理用品股份有限公司 （地址：重庆市江北区海尔路 389 号） 首次公开发行股票并在主板上市 招股说明书 声明：本公司的发行申请尚需经深圳证券交易所和中国证监会履行相应 程序。本招股说明书不具有据以发行股票的法律效力，仅供预先披露之用。 保荐人（主承销商） （住所：北京市朝阳区安立路 66 号 4 号楼） 1-1-1 （申报稿） 投资者应当以正式公告的招股说明书作为投资决定的依据。 重庆登康口腔护理用品股份有限公司 招股说明书 声明与发行概况 一、重要声明 中国证监会、交易所对本次发行所作的任何决定或意见，均不表明其对发 行人注册申请文件及所披露信息的真实性、准确性、完整性作出保证，也不表 明其对发行人的盈利能力、投资价值或者对投资者的收益作出实质性判断或保 证。任何与之相反的声明均属虚假不实陈述。 根据《证券法》规定，股票依法发行后，发行人经营与收益的变化，由发 行人自行负责；投资者自主判断发行人的投资价值，自主作出投资决策，自行 承担股票依法发行后因发行人经营与收益变化或者股票价格变动引致的投资风 险。 | 发行股票类型 | 人民币普通股（A 股） | | --- | --- | | 发行股数 ...